DK125588B - Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof. - Google Patents

Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Info

Publication number
DK125588B
DK125588B DK503669AA DK503669A DK125588B DK 125588 B DK125588 B DK 125588B DK 503669A A DK503669A A DK 503669AA DK 503669 A DK503669 A DK 503669A DK 125588 B DK125588 B DK 125588B
Authority
DK
Denmark
Prior art keywords
naphthalenone
hydroxypropoxy
butylamino
dihydro
tert
Prior art date
Application number
DK503669AA
Other languages
Danish (da)
Inventor
J Shavel
S Farber
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical filed Critical Warner Lambert Pharmaceutical
Priority to DK556671A priority Critical patent/DK129649B/en
Publication of DK125588B publication Critical patent/DK125588B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
DK503669AA 1968-09-23 1969-09-22 Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof. DK125588B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK556671A DK129649B (en) 1968-09-23 1971-11-12 Tetralone ether-containing material for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76185768A 1968-09-23 1968-09-23

Publications (1)

Publication Number Publication Date
DK125588B true DK125588B (en) 1973-03-12

Family

ID=25063434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK503669AA DK125588B (en) 1968-09-23 1969-09-22 Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.
DK556771AA DK128536B (en) 1968-09-23 1971-11-12 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK556771AA DK128536B (en) 1968-09-23 1971-11-12 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Country Status (15)

Country Link
US (1) US3641152A (en)
JP (1) JPS4843734B1 (en)
BE (1) BE739195A (en)
CH (1) CH525183A (en)
DE (2) DE1948144C3 (en)
DK (2) DK125588B (en)
ES (1) ES371737A1 (en)
FI (1) FI51936C (en)
FR (1) FR2018626B1 (en)
GB (1) GB1223527A (en)
IT (1) IT1033032B (en)
NL (1) NL139166B (en)
NO (1) NO128869B (en)
SE (1) SE362414B (en)
ZA (1) ZA695648B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755071A (en) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical METHOD FOR RESOLVING DL-5- / 3- (TERBUTYLAMINO) -2- HYDROXY-PROPOXY / -3,4-DIHYDRO-1 (2H) NAPHTHALENONE
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
DE2130393C3 (en) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanols and their salts with acids and their use in combating heart disease
FR2119843B1 (en) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5122737Y2 (en) * 1972-12-30 1976-06-11
US3966749A (en) * 1975-02-10 1976-06-29 Interx Research Corporation Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof
GB1493848A (en) * 1975-07-24 1977-11-30 Beecham Group Ltd Aryltetralins
CH621330A5 (en) * 1976-05-14 1981-01-30 Sandoz Ag
DE2810869A1 (en) * 1977-03-24 1978-09-28 Sandoz Ag 3-AMINO-2-HYDROXYPROPOXY DERIVATIVES, THEIR PRODUCTION AND USE
US4176183A (en) * 1977-05-02 1979-11-27 Merck & Co., Inc. Novel naphthyridines
US4270005A (en) * 1977-11-14 1981-05-26 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
CH641147A5 (en) * 1979-01-17 1984-02-15 Sandoz Ag 3-AMINO-2-HYDROXYPROPOXYARYL DERIVATIVE, ITS PREPARATION AND REMEDIES CONTAINING THEREOF.
DE2943406A1 (en) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
FR2507181A1 (en) * 1981-06-05 1982-12-10 Sanofi Sa NOVEL ETHERS OF PHENOL ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESS FOR PREPARING THEM AND USE THEREOF IN MEDICAMENTS
SE8801518D0 (en) * 1988-04-22 1988-04-22 Astra Pharma Prod A NOVEL PROCESS
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
ES2065278B1 (en) * 1993-06-24 1995-09-01 Medichem Sa LEVOBUNOLOL ENANTIOSELECTIVE PROCEDURE FOR OBTAINING.
ES2265437T3 (en) * 2000-07-27 2007-02-16 Pharmacia Corporation EPOXI-STEROID ANTAGONIST COMBINATION THERAPY OF ALDOSTERONE AND BETA-ADRENERGIC ANTAGONIST FOR TREATMENT OF CONGESTIVE CARDIAC INSUFFICIENCY.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023214A (en) * 1962-12-17 1966-03-23 Ici Ltd Carbocyclic hydroxyamines

Also Published As

Publication number Publication date
DK128536B (en) 1974-05-20
DE1948144B2 (en) 1979-05-03
NO128869B (en) 1974-01-21
BE739195A (en) 1970-03-23
US3641152A (en) 1972-02-08
FI51936C (en) 1977-05-10
JPS4843734B1 (en) 1973-12-20
DE1967162C3 (en) 1981-03-19
FR2018626A1 (en) 1970-06-26
DE1948144A1 (en) 1970-03-26
DE1948144C3 (en) 1980-01-17
IT1033032B (en) 1979-07-10
GB1223527A (en) 1971-02-24
CH525183A (en) 1972-07-15
NL6914077A (en) 1970-03-25
DE1967162B1 (en) 1980-07-31
FR2018626B1 (en) 1973-06-08
NL139166B (en) 1973-06-15
ES371737A1 (en) 1972-03-16
SE362414B (en) 1973-12-10
ZA695648B (en) 1971-03-31
FI51936B (en) 1977-01-31

Similar Documents

Publication Publication Date Title
DK125588B (en) Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.
DK108497C (en) Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK115473B (en) Process for the preparation of 2,3,4,5-tetrahydro-1H-3-benzazepines or acid addition salts thereof.
DK130070B (en) Analogous process for the preparation of 3,4-dihydroxyphenylalkanolamines or acid addition salts thereof.
DK113364B (en) Process for the preparation of 6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acids or alkali metal salts thereof.
DK124404B (en) Process for the preparation of 2-arylamino-1,3-diazacycloalkenes (2) or acid addition salts thereof.
DK131721B (en) Analogous process for the preparation of adamantanylamines or 3,5,7-trimethylhomologous or acid addition salts thereof.
DK117000B (en) Process for the preparation of substituted phenylamino-1,3-diazacyclopentenes (2) or acid addition salts thereof.
DK135231B (en) Analogous process for the preparation of basic substituted 2,3-cis, trans-diphenylcyclopropane derivatives or acid addition salts thereof.
DK115851B (en) Process for the preparation of 1,2-dihydro-4-aryl-quinazolines or acid addition salts thereof.
DK129994B (en) Analogous process for the preparation of 1-trimethoxybenzyl-6,7-dialkanoyl-1,2,3,4-tetrahydroisoquinolines or acid addition salts thereof.
DK129448B (en) Analogous process for the preparation of bis- (benzylideneamino) -guanidines or acid addition salts thereof.
DK121367B (en) Analogous process for the preparation of 3,3-diphenylallylamine derivatives or acid addition salts thereof.
DK122327B (en) Analogous process for the preparation of N-alkyllincomycin D compounds or acid addition salts thereof.
DK107942C (en) Process for the preparation of 1,5-disubstituted 3-aza-1-pentanols or acid addition salts thereof.
DK118657B (en) Analogous process for the preparation of 3 ', 4', 5'-trimethoxy-3-aminoacrylophenones or acid addition salts thereof.
DK118668B (en) Process for the preparation of tetrahydro-1,3,5-thiadiazin-2-thiones or acid addition salts thereof.
DK121955B (en) Analogous process for the preparation of 1,4-substituted phenylpiperazines or acid addition salts thereof.
DK117301B (en) Analogous process for the preparation of 3,6-disubstituted pyridazines or acid addition salts thereof.
DK121863B (en) Process for the preparation of 4-substituted 1,2-dihydroquinazoline-3-oxides or 3-deoxy derivatives thereof or these compounds acid addition salts.
DK125552B (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2-carboxamidines or acid addition salts thereof.
DK119705B (en) Process for the preparation of 4,5-disubstituted 2-alkyl-3-hydroxy-pyridines or acid addition salts thereof.
DK121375B (en) Analogous process for the preparation of N-aminoalkylbenzazacycloalkane derivatives or acid addition salts thereof.
DK107227C (en) Process for the preparation of 3,8-diazabicyclooctane derivatives of phentiazines, or acid addition salts thereof.
DK115994B (en) Process for the preparation of (3,5-diamino-6-halopyrazinoyl) -guanidine or (3,5-diamino-6-halopyrazinamido) -guanidine compounds or acid addition salts thereof.